Executive Management

Mark Maire
CEO

 

 

 

Mark started his career in ophthalmology in 1993 working first for J&J’s IOLab and then Chiron Vision. In 2008, he joined TrueVision Systems, Inc. in Santa Barbara, CA. As Chief Revenue Officer, Mark developed TrueVision’s partner strategy which created the first cash positive quarters. Together TrueVision and Cassini created the first ever surgical guidance and toric lens alignment software in ophthalmic surgery.

Mark brought in both Alcon ($7B spin-off from Novartis) and Aesculap ($2B division of B. Braun) as key strategic partners ultimately selling the ophthalmology assets to Alcon. The spin-off neurosurgery company, Digital Surgery Systems, is positioned for acquisition. Mark was named in the Alcon acquisition and worked as a National Surgical Consultant in visualization. He is a graduate of The University of Michigan, board member of LauchPoint EPS (aerospace) and brings over 30 years of business leadership and ophthalmology industry knowledge to Cassini Technologies.

 

 

Joris Vogels
Strategic Advisor

 

 

Joris is Strategic Advisor and co-founder of Cassini. With a background in sales, marketing and product development, Joris has extensive experience in bringing to market and commercializing innovative medical solutions. He has been responsible for the prostate and imaging business for radiation oncology company Nucletron. Joris also served as commercial manager and vice-president for i-Optics, being responsible for the introduction and commercialization of EasyScan, an innovative Retinal Imaging System. Joris holds an MSc in General Management from Nyenrode University.

 

 

Mark Packer, MD

Mark Packer, MD FACS CPI
Chief Medical Officer

 

 

Mark Packer is internationally recognized as a leader in ophthalmology, the author of original research establishing innovative techniques and groundbreaking technologies.

He is widely sought after for his medical, clinical and regulatory expertise by companies in the medical device and pharmaceutical space, including Abbott Medical Optics, Advanced Vision Science, Aerie Pharmaceuticals, Alcon Laboratories, Allergan, Bausch & Lomb, Cassini, General Electric Health Care, International Biomedical Devices, Johnson & Johnson, Lensar, Oculeve, Promedica International, Rayner, Refocus Group, SOLX, STAAR Surgical, Transcend Medical, True Vision Systems, VisionCare Ophthalmic Technologies and WaveTec Vision Systems. He has served as Principal Investigator or Medical Monitor in over sixty clinical trial protocols leading to FDA clearances and approvals.